Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2b, Double-Blind, Placebo-Controlled, Multinational, Multicenter, Randomized Study Evaluating the Safety and Efficacy of Intracoronary Administration of MYDICAR® (AAV1/SERCA2a) in Subjects With Heart Failure

NCT01643330 is registered in ClinicalTrials.gov with Celladon Corporation as lead sponsor.

NCT NCT01643330
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01643330 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2b, Double-Blind, Placebo-Controlled, Multinational, Multicenter, Randomized Study Evaluating the Safety and Efficacy of Intracoronary Administration of MYDICAR® (AAV1/SERCA2a) in Subjects With Heart Failure
Lead sponsor
Celladon Corporation
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2012
Completion date
February 29, 2016
Enrollment
250 (actual)
Sites
54

Conditions

As the registry lists them; a condition with its own page is linked.

cardiomyopathies, heart failure, ischemic cardiomyopathy, non-ischemic cardiomyopathy